Advertisement

Topics

Saul Ewing Company Profile

10:50 EDT 24th June 2018 | BioPortfolio

At Saul Ewing, we are dedicated to the key values of excellence, energy and enthusiasm: excellence in our legal services, the energy to succeed, and an enthusiasm for understanding and being responsive to our clients' needs. These core values are the hallmarks of our more than eight decades of service to clients.

Location

Lockwood Place500 East Pratt Street, Suite 900
Baltimore
Maryland
21202-3171
United States of America

Contact

Phone: 410.332.8600
Fax: 410.332.8862


News Articles [28 Associated News Articles listed on BioPortfolio]

A potential new therapeutic target for Ewing sarcoma

(IDIBELL-Bellvitge Biomedical Research Institute) IDIBELL researchers correlate EphA2 membrane receptor with the metastatic capacity of tumors in Ewing sarcoma.Ewing sarcoma is the second most frequen...

Cancer researchers hit a bullseye with new drug target for Ewing sarcoma

(Boston Children's Hospital) Kimberly Stegmaier of Dana-Farber/Boston Children's Cancer and Blood Disorders Center and collaborators have found that Ewing sarcoma cells die if an enzyme called CDK12 i...

Link between BRCA1 and Ewing sarcoma

Scientists have discovered a surprising connection between a breast cancer protein, BRCA1, and a pediatric cancer called Ewing sarcoma.

Ewing Sarcoma Epidemiology Forecast to 2027 [Report Updated: 14022018] Prices from USD $3250

DelveInsight's "Ewing Sarcoma Epidemiology Forecast, 2027 report provides a comprehensive analysis of the Ewing Sarcoma epidemiology, providing the historical and forecasted data for the 7MM during...

New approach identifies existing leukaemia drugs that show promise for Ewing sarcoma treatment

Scientists in the United States have discovered that two existing FDA-approved drugs, clofarabine (Clolar™) and cladribine (Leustatin™), have a powerful inhibitory impact on Ewing sarcom...

Ewing Sarcoma Pipeline Review, H1 2018 – Therapeutics Development Analyzed, Key Companies Involved and Drug Profiles Covered – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ewing Sarcoma – Pipeline Review, H1 2018” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive...

Link between BRCA1 and Ewing sarcoma found

Scientists with the Greehey Children's Cancer Research Institute at UT Health San Antonio have discovered a surprising connection between a breast cancer protein, BRCA1, and a paediatric cancer called...

Researchers discover potential new therapeutic target for Ewing sarcoma

The sarcoma research group of the Bellvitge Biomedical Research Institute, led by Dr. Òscar Martínez-Tirado, has identified a potential new therapeutic target for Ewing sarcoma, the second most freq...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Cosmegen [Lundbeck Inc.]

Cosmegen for Injection (dactinomycin for injection) (Actinomycin D) Rx only

PubMed Articles [42 Associated PubMed Articles listed on BioPortfolio]

A congenital soft tissue Ewing sarcoma in a newborn patient.

Akçalı M, Yapıcıoğlu H, Akay E, Özlü F, Kozanoğlu B, Erdoğan K, Gönlüşen G, Satar M. A congenital soft tissue Ewing sarcoma in a newborn patient. Turk J Pediatr 2017; 59: 76-79. < p < Cong...

Periosteal Ewing Sarcoma in a 65-Year-Old Man: A Case Report.

Ewing sarcoma is predominantly a pediatric bone malignancy involving the medullary canal. Periosteal Ewing sarcoma, a subtype arising from the periosteum, is exceedingly rare, with approximately 30 re...

EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma.

Ewing sarcoma is an aggressive paediatric cancer of the bone and soft tissue. It results from a chromosomal translocation, predominantly t(11;22)(q24:q12), that fuses the N-terminal transactivation do...

Award for Distinguished Contributions to Research in Public Policy: Saul M. Kassin.

APA's Award for Distinguished Contributions to Research in Public Policy is given to a psychologist who has made a distinguished empirical and/or theoretical contribution to research in public policy,...

Planning for Bone Excision in Ewing Sarcoma: Post-Chemotherapy MRI More Accurate Than Pre-Chemotherapy MRI Assessment.

In determining the level of bone resection in Ewing sarcoma, the most suitable time at which to perform magnetic resonance imaging (MRI) remains controversial. Current guidelines recommend that surgic...

Clinical Trials [59 Associated Clinical Trials listed on BioPortfolio]

Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma

Despite improvements in outcomes for patients with localized Ewing sarcoma, patients with relapsed metastatic Ewing sarcoma continue to have poor outcomes with current chemotherapy options...

TK216 in Patients With Relapsed or Refractory Ewing Sarcoma

Ewing sarcoma is characterized by genomic rearrangements resulting in over-expression of ets family transcription factors driving tumor progression. TK216 is designed to inhibit this effec...

Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors

This is a phase 1 study of anti-IGF-IR CP-751,871 in patients with solid tumors currently enrolling patients 9 years old and older with Ewing's sarcoma family of tumors (Ewing's, PNET and ...

Anlotinib and Irinotecan for Ewing Sarcoma

The investigators explored the activity of anlotinib combined with irinotecan in patients with relapsed and metastatic Ewing Sarcoma.

Irinotecan and Temozolomide for Ewing Sarcoma

The investigators explored the activity of irinotecan combined with temozolomide in patients with relapsed and metastatic Ewing Sarcoma.

Companies [10 Associated Companies listed on BioPortfolio]

Saul Ewing

At Saul Ewing, we are dedicated to the key values of excellence, energy and enthusiasm: excellence in our legal services, the energy to succeed, and an enthusiasm for understanding and being responsiv...

Stringer Saul LLP

Stringer Saul LLP is a commercial law practice which has developed substantial legal capabilities in its practice areas and market expertise in certain industry sectors. We recognise that our clients ...

The iBridge Network

The iBridgeSM Network is a program of the Kauffman Innovation Network, Inc., an initiative of the Ewing Marion Kauffman Foundation. To learn more, please visit www.iBridgeNetwork....

1 Million 4 Anna Foundation

The 1 Million 4 Anna Foundation strives to further Anna’s legacy and embody her fighting spirit by winning the fight against Ewing’s Sarcoma today, tomorrow, and until i...

iBridge Network

The iBridge(SM) Network is an innovation catalyst with a vibrant, online community enabling universities, companies and entrepreneurs to connect, collaborate and license tomorrow's research, products ...

More Information about "Saul Ewing" on BioPortfolio

We have published hundreds of Saul Ewing news stories on BioPortfolio along with dozens of Saul Ewing Clinical Trials and PubMed Articles about Saul Ewing for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Saul Ewing Companies in our database. You can also find out about relevant Saul Ewing Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record